Enlivex Announces Enrollment And Dosing Of First 10 Patients In The Randomized Phase II Stage Of Its Allocetra Trial For Patients With Moderate To Severe Knee Osteoarthritis
Enlivex Announces Enrollment And Dosing Of First 10 Patients In The Randomized Phase II Stage Of Its Allocetra Trial For Patients With Moderate To Severe Knee Osteoarthritis
Enlivex宣佈在其Allocetra試驗的隨機II期階段中招募和爲首批10名中重度膝關節骨關節炎患者進行服藥。
Enlivex Announces Enrollment And Dosing Of First 10 Patients In The Randomized Phase II Stage Of Its Allocetra Trial For Patients With Moderate To Severe Knee Osteoarthritis
Enlivex宣佈前10名患有中重度膝關節骨關節炎的患者已經完成隨機分組的第二階段Allocetra試驗的入組和給藥。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間